Contact Regional Sites About Technologies & Innovations Services Products Career Your subcontractor for the development and manufacturing of health products that facilitate patients’ lives Our Sites Eight strategic locations on four continents. We currently employ 1,500 experienced and specialised employees at our five industrial sites, our R&D centre and our sales offices. Read more Licences & Partnerships In addition to its CDMO services, Unither Pharmaceuticals offers other types of collaboration based on its technological platforms (BFS, vials, etc.): Co-development and out-licensing files developed internally Read more Technologies & Innovations Unither offers a wide range of pharmaceutical manufacturing and packaging technologies: Blow-Fill-Seal (BFS) technology, Preservative-free multidose, liquid stick-packs, bottles and sprays, tablets and capsules and suppositories and pessaries. Read more Our Services At Unither, innovation and development are key words: we offer our customers and their patients adapted technologies. To this end, we are constantly developing new solutions and cutting-edge formulations for unit doses. Read more Unither Pharmaceuticals Thanks to more than 25 years of experience and constant innovation, French pharmaceutical company Unither has established itself as a world leading contract manufacturer of pharmaceutical products. Play video Join us ! We offer opportunities worldwide! Consult Events News About Technologies & Innovations Services Products Contact Follow us Subscribe to the newsletter I would like to receive the Unither newsletter. To view our privacy policy click here. Confidentiality Code of Conduct Legal disclaimer Sitemap Purchasing Policy © 2021 Unither

Contact Regional Sites In regards to Technologies & Innovations Services Products Career TECHNOLOGIES & INNOVATIONS Innovation: Uniflash® (oral transmucosal) Uniflash®: Needle-free injection Uniflash® is a single dose solution for oral transmucosal (BTM) administration. The efficacy and rapidity of action of this new, non-invasive administration route are comparable to that of an intravenous injection. Thanks to this patented technology, lipophilic or amphiphilic molecules are rapidly absorbed through the oral mucosa. This highly vascularized mucosa allows the drug to pass quickly into the blood. It also makes it possible to considerably reduce the famous “hepatic first pass effect” and therefore to reduce the quantity of active principle to be absorbed at each dose, thus limiting the potential undesirable effects of the drug. MDSC Flasks Liquid stick-packs In regards to Technologies & Innovations Our services Products Contact follow us Subscribe to the newsletter I would like to receive the Unither newsletters. To view our privacy policy click here . Confidentiality Code of conduct Legal Notice Sitemap Purchasing Policy © 2021 Unither